An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael W Platt, Mikael H Sodergren · 2023
Read An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry by Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael W Platt, Mikael H Sodergren (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10739137.txt.
Description
Simon Erridge and co-authors tracked cannabis medicines on a UK registry in two thousand twenty-three. Patients report quality of life gains from these products. But studied products vary wildly between trials. This registry used one brand family throughout. Nearly fourteen hundred patients entered the final analysis. Their outcomes were followed for a full year.
Patient-reported measures were taken at set intervals. Adverse events were logged alongside the benefits. Many patients already used cannabis at baseline. Scores shifted from baseline across the months. Homogeneity makes the pattern easier to read. The registry approach trades randomization for realism. Clinicians gain a large, consistent evidence base.
Catalog record
| CREATOR | Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael W Platt, Mikael H Sodergren |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |